nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PGR—polycystic ovary syndrome	0.499	0.643	CbGaD
Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.278	0.357	CbGaD
Fluticasone Propionate—PGR—corpus luteum—polycystic ovary syndrome	0.018	0.204	CbGeAlD
Fluticasone Propionate—PGR—ovarian follicle—polycystic ovary syndrome	0.0141	0.159	CbGeAlD
Fluticasone Propionate—Sinus headache—Metformin—polycystic ovary syndrome	0.00459	0.128	CcSEcCtD
Fluticasone Propionate—NR3C1—urine—polycystic ovary syndrome	0.0034	0.0384	CbGeAlD
Fluticasone Propionate—CYP3A4—urine—polycystic ovary syndrome	0.00257	0.0291	CbGeAlD
Fluticasone Propionate—PLA2G4A—adrenal cortex—polycystic ovary syndrome	0.00206	0.0233	CbGeAlD
Fluticasone Propionate—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00185	0.0513	CcSEcCtD
Fluticasone Propionate—PLA2G4A—endometrium—polycystic ovary syndrome	0.00184	0.0208	CbGeAlD
Fluticasone Propionate—Contusion—Metformin—polycystic ovary syndrome	0.00171	0.0477	CcSEcCtD
Fluticasone Propionate—NR3C2—adrenal cortex—polycystic ovary syndrome	0.00168	0.019	CbGeAlD
Fluticasone Propionate—PLA2G4A—pituitary gland—polycystic ovary syndrome	0.00167	0.0189	CbGeAlD
Fluticasone Propionate—PLA2G4A—adipose tissue—polycystic ovary syndrome	0.00166	0.0188	CbGeAlD
Fluticasone Propionate—SERPINA6—pituitary gland—polycystic ovary syndrome	0.00166	0.0188	CbGeAlD
Fluticasone Propionate—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00161	0.0183	CbGeAlD
Fluticasone Propionate—NR3C2—endometrium—polycystic ovary syndrome	0.0015	0.017	CbGeAlD
Fluticasone Propionate—PLA2G4A—adrenal gland—polycystic ovary syndrome	0.00149	0.0169	CbGeAlD
Fluticasone Propionate—SERPINA6—adrenal gland—polycystic ovary syndrome	0.00148	0.0168	CbGeAlD
Fluticasone Propionate—PGR—endometrium—polycystic ovary syndrome	0.00139	0.0158	CbGeAlD
Fluticasone Propionate—PLA2G4A—female gonad—polycystic ovary syndrome	0.00139	0.0157	CbGeAlD
Fluticasone Propionate—NR3C2—uterus—polycystic ovary syndrome	0.00138	0.0156	CbGeAlD
Fluticasone Propionate—PLA2G4A—vagina—polycystic ovary syndrome	0.00138	0.0156	CbGeAlD
Fluticasone Propionate—NR3C2—pituitary gland—polycystic ovary syndrome	0.00136	0.0153	CbGeAlD
Fluticasone Propionate—NR3C2—adipose tissue—polycystic ovary syndrome	0.00135	0.0153	CbGeAlD
Fluticasone Propionate—Lightheadedness—Metformin—polycystic ovary syndrome	0.00134	0.0372	CcSEcCtD
Fluticasone Propionate—PLA2G4A—endocrine gland—polycystic ovary syndrome	0.00129	0.0146	CbGeAlD
Fluticasone Propionate—SERPINA6—endocrine gland—polycystic ovary syndrome	0.00129	0.0146	CbGeAlD
Fluticasone Propionate—PGR—uterus—polycystic ovary syndrome	0.00128	0.0145	CbGeAlD
Fluticasone Propionate—PGR—pituitary gland—polycystic ovary syndrome	0.00126	0.0143	CbGeAlD
Fluticasone Propionate—PGR—adipose tissue—polycystic ovary syndrome	0.00126	0.0142	CbGeAlD
Fluticasone Propionate—NR3C2—adrenal gland—polycystic ovary syndrome	0.00121	0.0137	CbGeAlD
Fluticasone Propionate—Nasal congestion—Metformin—polycystic ovary syndrome	0.00119	0.0331	CcSEcCtD
Fluticasone Propionate—NR3C2—female gonad—polycystic ovary syndrome	0.00113	0.0128	CbGeAlD
Fluticasone Propionate—PGR—adrenal gland—polycystic ovary syndrome	0.00113	0.0127	CbGeAlD
Fluticasone Propionate—NR3C2—vagina—polycystic ovary syndrome	0.00112	0.0127	CbGeAlD
Fluticasone Propionate—NR3C1—embryo—polycystic ovary syndrome	0.0011	0.0124	CbGeAlD
Fluticasone Propionate—NR3C2—endocrine gland—polycystic ovary syndrome	0.00105	0.0119	CbGeAlD
Fluticasone Propionate—PGR—female gonad—polycystic ovary syndrome	0.00105	0.0119	CbGeAlD
Fluticasone Propionate—PGR—vagina—polycystic ovary syndrome	0.00104	0.0118	CbGeAlD
Fluticasone Propionate—Cramp muscle—Metformin—polycystic ovary syndrome	0.000977	0.0272	CcSEcCtD
Fluticasone Propionate—PGR—endocrine gland—polycystic ovary syndrome	0.000976	0.011	CbGeAlD
Fluticasone Propionate—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000971	0.027	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Metformin—polycystic ovary syndrome	0.000944	0.0263	CcSEcCtD
Fluticasone Propionate—NR3C1—adrenal cortex—polycystic ovary syndrome	0.0009	0.0102	CbGeAlD
Fluticasone Propionate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000899	0.025	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000872	0.0242	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Metformin—polycystic ovary syndrome	0.000836	0.0233	CcSEcCtD
Fluticasone Propionate—Infestation—Metformin—polycystic ovary syndrome	0.000836	0.0233	CcSEcCtD
Fluticasone Propionate—NR3C1—endometrium—polycystic ovary syndrome	0.000804	0.00909	CbGeAlD
Fluticasone Propionate—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000747	0.0208	CcSEcCtD
Fluticasone Propionate—NR3C1—uterus—polycystic ovary syndrome	0.00074	0.00838	CbGeAlD
Fluticasone Propionate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000738	0.0205	CcSEcCtD
Fluticasone Propionate—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00073	0.00826	CbGeAlD
Fluticasone Propionate—NR3C1—pituitary gland—polycystic ovary syndrome	0.000727	0.00823	CbGeAlD
Fluticasone Propionate—NR3C1—adipose tissue—polycystic ovary syndrome	0.000724	0.0082	CbGeAlD
Fluticasone Propionate—Eye disorder—Metformin—polycystic ovary syndrome	0.000702	0.0195	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000697	0.0194	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Metformin—polycystic ovary syndrome	0.000678	0.0189	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000677	0.0188	CcSEcCtD
Fluticasone Propionate—Erythema—Metformin—polycystic ovary syndrome	0.000654	0.0182	CcSEcCtD
Fluticasone Propionate—Malnutrition—Metformin—polycystic ovary syndrome	0.000654	0.0182	CcSEcCtD
Fluticasone Propionate—NR3C1—adrenal gland—polycystic ovary syndrome	0.00065	0.00735	CbGeAlD
Fluticasone Propionate—Muscle spasms—Metformin—polycystic ovary syndrome	0.000628	0.0175	CcSEcCtD
Fluticasone Propionate—Vision blurred—Metformin—polycystic ovary syndrome	0.000616	0.0171	CcSEcCtD
Fluticasone Propionate—Tremor—Metformin—polycystic ovary syndrome	0.000612	0.017	CcSEcCtD
Fluticasone Propionate—CYP3A5—female gonad—polycystic ovary syndrome	0.00061	0.00691	CbGeAlD
Fluticasone Propionate—CYP3A5—vagina—polycystic ovary syndrome	0.000607	0.00687	CbGeAlD
Fluticasone Propionate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000606	0.0169	CcSEcCtD
Fluticasone Propionate—NR3C1—female gonad—polycystic ovary syndrome	0.000606	0.00685	CbGeAlD
Fluticasone Propionate—NR3C1—vagina—polycystic ovary syndrome	0.000602	0.00681	CbGeAlD
Fluticasone Propionate—Malaise—Metformin—polycystic ovary syndrome	0.000589	0.0164	CcSEcCtD
Fluticasone Propionate—Palpitations—Metformin—polycystic ovary syndrome	0.000578	0.0161	CcSEcCtD
Fluticasone Propionate—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000568	0.00642	CbGeAlD
Fluticasone Propionate—Hypertension—Metformin—polycystic ovary syndrome	0.000564	0.0157	CcSEcCtD
Fluticasone Propionate—NR3C1—endocrine gland—polycystic ovary syndrome	0.000563	0.00637	CbGeAlD
Fluticasone Propionate—Chest pain—Metformin—polycystic ovary syndrome	0.000556	0.0155	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000553	0.0154	CcSEcCtD
Fluticasone Propionate—Discomfort—Metformin—polycystic ovary syndrome	0.00055	0.0153	CcSEcCtD
Fluticasone Propionate—Oedema—Metformin—polycystic ovary syndrome	0.000533	0.0148	CcSEcCtD
Fluticasone Propionate—Infection—Metformin—polycystic ovary syndrome	0.00053	0.0147	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000523	0.0145	CcSEcCtD
Fluticasone Propionate—Skin disorder—Metformin—polycystic ovary syndrome	0.000518	0.0144	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000486	0.0135	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Metformin—polycystic ovary syndrome	0.000476	0.0132	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00044	0.0122	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000436	0.0121	CcSEcCtD
Fluticasone Propionate—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000426	0.00482	CbGeAlD
Fluticasone Propionate—Urticaria—Metformin—polycystic ovary syndrome	0.000424	0.0118	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Metformin—polycystic ovary syndrome	0.000422	0.0117	CcSEcCtD
Fluticasone Propionate—Difluprednate—NR3C1—polycystic ovary syndrome	0.000404	0.0525	CrCbGaD
Fluticasone Propionate—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000392	0.0509	CrCbGaD
Fluticasone Propionate—Clocortolone—NR3C1—polycystic ovary syndrome	0.000392	0.0509	CrCbGaD
Fluticasone Propionate—Pruritus—Metformin—polycystic ovary syndrome	0.000377	0.0105	CcSEcCtD
Fluticasone Propionate—Diflorasone—NR3C1—polycystic ovary syndrome	0.000371	0.0482	CrCbGaD
Fluticasone Propionate—Diarrhoea—Metformin—polycystic ovary syndrome	0.000365	0.0102	CcSEcCtD
Fluticasone Propionate—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000362	0.047	CrCbGaD
Fluticasone Propionate—Dizziness—Metformin—polycystic ovary syndrome	0.000353	0.00981	CcSEcCtD
Fluticasone Propionate—Vomiting—Metformin—polycystic ovary syndrome	0.000339	0.00943	CcSEcCtD
Fluticasone Propionate—Rash—Metformin—polycystic ovary syndrome	0.000336	0.00935	CcSEcCtD
Fluticasone Propionate—Dermatitis—Metformin—polycystic ovary syndrome	0.000336	0.00935	CcSEcCtD
Fluticasone Propionate—Headache—Metformin—polycystic ovary syndrome	0.000334	0.00929	CcSEcCtD
Fluticasone Propionate—Nausea—Metformin—polycystic ovary syndrome	0.000317	0.00881	CcSEcCtD
Fluticasone Propionate—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000311	0.0404	CrCbGaD
Fluticasone Propionate—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.000306	0.0398	CrCbGaD
Fluticasone Propionate—Amcinonide—NR3C1—polycystic ovary syndrome	0.000285	0.037	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—NR3C1—polycystic ovary syndrome	0.000279	0.0363	CrCbGaD
Fluticasone Propionate—Betamethasone—PGR—polycystic ovary syndrome	0.000277	0.0359	CrCbGaD
Fluticasone Propionate—Mometasone—NR3C1—polycystic ovary syndrome	0.000271	0.0352	CrCbGaD
Fluticasone Propionate—Rimexolone—NR3C1—polycystic ovary syndrome	0.000268	0.0348	CrCbGaD
Fluticasone Propionate—Beclomethasone—NR3C1—polycystic ovary syndrome	0.000252	0.0328	CrCbGaD
Fluticasone Propionate—Fluocinonide—NR3C1—polycystic ovary syndrome	0.000252	0.0328	CrCbGaD
Fluticasone Propionate—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000245	0.0319	CrCbGaD
Fluticasone Propionate—Alclometasone—NR3C1—polycystic ovary syndrome	0.000245	0.0319	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000239	0.031	CrCbGaD
Fluticasone Propionate—Flunisolide—NR3C1—polycystic ovary syndrome	0.000239	0.031	CrCbGaD
Fluticasone Propionate—Paramethasone—NR3C1—polycystic ovary syndrome	0.000236	0.0306	CrCbGaD
Fluticasone Propionate—Fluorometholone—NR3C1—polycystic ovary syndrome	0.00023	0.0299	CrCbGaD
Fluticasone Propionate—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000223	0.0289	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000217	0.0282	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000217	0.0282	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000213	0.0277	CrCbGaD
Fluticasone Propionate—Betamethasone—CYP19A1—polycystic ovary syndrome	0.00019	0.0247	CrCbGaD
Fluticasone Propionate—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000188	0.0244	CrCbGaD
Fluticasone Propionate—Dexamethasone—PGR—polycystic ovary syndrome	0.000161	0.0209	CrCbGaD
Fluticasone Propionate—Betamethasone—NR3C1—polycystic ovary syndrome	0.000154	0.02	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.00011	0.0143	CrCbGaD
Fluticasone Propionate—Dexamethasone—NR3C1—polycystic ovary syndrome	8.94e-05	0.0116	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP1A1—polycystic ovary syndrome	8.12e-05	0.0106	CrCbGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	5.11e-05	0.000562	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.11e-05	0.000561	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKR1C2—polycystic ovary syndrome	5.08e-05	0.000558	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TEAD2—polycystic ovary syndrome	5.08e-05	0.000558	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	5.08e-05	0.000558	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	5.06e-05	0.000555	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	5.04e-05	0.000554	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	5.04e-05	0.000554	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	5.02e-05	0.000551	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.97e-05	0.000546	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NR3C1—polycystic ovary syndrome	4.95e-05	0.000543	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.94e-05	0.000543	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HMMR—polycystic ovary syndrome	4.93e-05	0.000541	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.85e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INHBB—polycystic ovary syndrome	4.85e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	4.84e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	4.76e-05	0.000522	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.74e-05	0.000521	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	4.73e-05	0.000519	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HSD3B1—polycystic ovary syndrome	4.7e-05	0.000516	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	4.65e-05	0.000511	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	4.65e-05	0.00051	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	4.65e-05	0.00051	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.65e-05	0.00051	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.61e-05	0.000507	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	4.53e-05	0.000497	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.52e-05	0.000497	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FST—polycystic ovary syndrome	4.5e-05	0.000494	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	4.47e-05	0.000491	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	4.47e-05	0.000491	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.44e-05	0.000488	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.41e-05	0.000484	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	4.4e-05	0.000483	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	4.39e-05	0.000482	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.37e-05	0.00048	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	4.32e-05	0.000475	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	4.31e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.29e-05	0.000471	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—LHB—polycystic ovary syndrome	4.29e-05	0.000471	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	4.26e-05	0.000468	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	4.22e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	4.21e-05	0.000462	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—HSD3B2—polycystic ovary syndrome	4.19e-05	0.00046	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	4.15e-05	0.000456	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.15e-05	0.000456	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FSHR—polycystic ovary syndrome	4.12e-05	0.000452	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	4.11e-05	0.000451	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	4.11e-05	0.000451	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKR1C1—polycystic ovary syndrome	4.06e-05	0.000446	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	4.04e-05	0.000443	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.01e-05	0.00044	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.92e-05	0.000431	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.91e-05	0.000429	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.87e-05	0.000425	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	3.85e-05	0.000423	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	3.85e-05	0.000423	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PPARG—polycystic ovary syndrome	3.83e-05	0.000421	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	3.82e-05	0.00042	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	3.77e-05	0.000414	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.77e-05	0.000414	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SULT2A1—polycystic ovary syndrome	3.73e-05	0.00041	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AR—polycystic ovary syndrome	3.73e-05	0.000409	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	3.67e-05	0.000404	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	3.67e-05	0.000404	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FST—polycystic ovary syndrome	3.67e-05	0.000403	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.63e-05	0.000398	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—RRM2—polycystic ovary syndrome	3.62e-05	0.000397	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LHB—polycystic ovary syndrome	3.58e-05	0.000394	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	3.57e-05	0.000392	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	3.52e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.5e-05	0.000385	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—YAP1—polycystic ovary syndrome	3.49e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IGF1—polycystic ovary syndrome	3.47e-05	0.000381	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT2—polycystic ovary syndrome	3.47e-05	0.000381	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SERPINE1—polycystic ovary syndrome	3.45e-05	0.000379	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	3.43e-05	0.000377	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.39e-05	0.000373	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	3.37e-05	0.00037	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SCT—polycystic ovary syndrome	3.36e-05	0.000369	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NAMPT—polycystic ovary syndrome	3.35e-05	0.000368	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	3.33e-05	0.000366	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.33e-05	0.000366	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.32e-05	0.000364	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP11A1—polycystic ovary syndrome	3.31e-05	0.000363	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SERPINE1—polycystic ovary syndrome	3.3e-05	0.000362	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	3.29e-05	0.000361	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	3.29e-05	0.000361	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.28e-05	0.000361	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	3.28e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	3.26e-05	0.000358	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.2e-05	0.000352	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.2e-05	0.000351	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	3.17e-05	0.000348	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF18—polycystic ovary syndrome	3.15e-05	0.000346	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.15e-05	0.000346	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKR1C3—polycystic ovary syndrome	3.12e-05	0.000343	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RBP4—polycystic ovary syndrome	3.12e-05	0.000343	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	3.08e-05	0.000338	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP17A1—polycystic ovary syndrome	3.08e-05	0.000338	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.07e-05	0.000338	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	3.01e-05	0.000331	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	2.99e-05	0.000328	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	2.92e-05	0.000321	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	2.92e-05	0.000321	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.92e-05	0.00032	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	2.9e-05	0.000318	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	2.9e-05	0.000318	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.88e-05	0.000316	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.84e-05	0.000312	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	2.83e-05	0.000311	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.8e-05	0.000308	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	2.8e-05	0.000307	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	2.79e-05	0.000306	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	2.77e-05	0.000304	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	2.76e-05	0.000303	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INSR—polycystic ovary syndrome	2.75e-05	0.000302	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.7e-05	0.000296	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.69e-05	0.000295	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TH—polycystic ovary syndrome	2.66e-05	0.000292	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.65e-05	0.000291	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.61e-05	0.000287	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	2.6e-05	0.000286	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC2A4—polycystic ovary syndrome	2.59e-05	0.000284	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.57e-05	0.000282	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	2.55e-05	0.00028	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PGR—polycystic ovary syndrome	2.55e-05	0.00028	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	2.53e-05	0.000278	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.53e-05	0.000277	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	2.52e-05	0.000277	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	2.48e-05	0.000273	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP19A1—polycystic ovary syndrome	2.43e-05	0.000267	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	2.43e-05	0.000267	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.4e-05	0.000263	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	2.37e-05	0.00026	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.37e-05	0.00026	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.37e-05	0.00026	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.36e-05	0.000259	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—polycystic ovary syndrome	2.33e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	2.33e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	2.31e-05	0.000253	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—polycystic ovary syndrome	2.27e-05	0.000249	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.26e-05	0.000248	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	2.22e-05	0.000244	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.2e-05	0.000242	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	2.18e-05	0.000239	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GNAS—polycystic ovary syndrome	2.17e-05	0.000239	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.16e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.16e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	2.16e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AR—polycystic ovary syndrome	2.15e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	2.14e-05	0.000235	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.12e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	2.11e-05	0.000232	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	2.1e-05	0.000231	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.08e-05	0.000229	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	2.08e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.07e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NCOR1—polycystic ovary syndrome	2.07e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRL—polycystic ovary syndrome	2.06e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	2.04e-05	0.000224	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.01e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.99e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1A1—polycystic ovary syndrome	1.96e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.96e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	1.88e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	1.88e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TH—polycystic ovary syndrome	1.85e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—polycystic ovary syndrome	1.83e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	1.82e-05	0.0002	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.82e-05	0.000199	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	1.8e-05	0.000198	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.78e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	1.76e-05	0.000193	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	1.74e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.73e-05	0.00019	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.71e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.71e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.7e-05	0.000187	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	1.7e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	1.69e-05	0.000185	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	1.67e-05	0.000183	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.57e-05	0.000173	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.55e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.55e-05	0.00017	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	1.51e-05	0.000166	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	1.5e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INS—polycystic ovary syndrome	1.49e-05	0.000163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—polycystic ovary syndrome	1.48e-05	0.000163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—POMC—polycystic ovary syndrome	1.46e-05	0.000161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.45e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—INS—polycystic ovary syndrome	1.45e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	1.44e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.44e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.44e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.43e-05	0.000157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—polycystic ovary syndrome	1.42e-05	0.000156	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.37e-05	0.00015	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	1.37e-05	0.00015	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.36e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.35e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.34e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.29e-05	0.000142	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	1.27e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.27e-05	0.000139	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.23e-05	0.000135	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—POMC—polycystic ovary syndrome	1.22e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INS—polycystic ovary syndrome	1.22e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.22e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.18e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.18e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.15e-05	0.000127	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.12e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.1e-05	0.000121	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	1.03e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	1.02e-05	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—INS—polycystic ovary syndrome	1.01e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1e-05	0.00011	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	9.88e-06	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.81e-06	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	9.5e-06	0.000104	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.41e-06	0.000103	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	9.21e-06	0.000101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—polycystic ovary syndrome	9e-06	9.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.75e-06	9.6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.47e-06	9.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.17e-06	8.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.84e-06	8.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.75e-06	8.51e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.68e-06	8.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	7.47e-06	8.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	7.37e-06	8.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—INS—polycystic ovary syndrome	7.33e-06	8.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.32e-06	8.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.2e-06	7.91e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	6.51e-06	7.14e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.23e-06	6.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.06e-06	6.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.7e-06	6.26e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—polycystic ovary syndrome	5.31e-06	5.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.09e-06	5.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.85e-06	5.32e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.59e-06	5.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.28e-06	4.7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.47e-06	3.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.43e-06	3.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.41e-06	3.74e-05	CbGpPWpGaD
